$96.64
-2.40 (-2.42%)
Performance
1D
—
1W
+0.08%
1M
+19.53%
3M
-8.25%
6M
+26.44%
1Y
+331.62%
YTD
+216.02%
Open$98.56
Previous Close$99.04
Day High$98.76
Day Low$93.83
52W High$110.18
52W Low$21.15
Volume—
Avg Volume958.8K
Market Cap8.90B
P/E Ratio—
EPS$-2.32
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$89.52
Above
SMA 200
$74.19
Above
RSI (14)
78.3
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-18.3% upside
Current
$96.64
$96.64
Target
$78.92
$78.92
$58.92
$78.92 avg
$128.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 469.29M | 433.92M | 481.69M |
| Net Income | -23,759,261 | -24,167,490 | -23,392,315 |
| Profit Margin | -5.1% | -5.6% | -4.9% |
| EBITDA | -33,340,073 | -28,197,061 | -36,465,134 |
| Free Cash Flow | -26,670,161 | -19,444,681 | -29,871,207 |
| Rev Growth | +18.1% | +19.4% | +22.5% |
| Debt/Equity | 0.73 | 0.87 | 0.77 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |